Nuwiq powder and solvent for solution for injection
- Name:
Nuwiq powder and solvent for solution for injection
- Company:
Octapharma Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 05/09/19
(Click to Download)Click on this link to Download PDF directly
Octapharma Ltd
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name albunorm 20% | Active Ingredients Human Albumin |
| Medicine Name Fibryga, 1 g, powder and solvent for solution for injection/infusion | Active Ingredients Human Fibrinogen |
| Medicine Name gammanorm | Active Ingredients Human Normal Immunoglobulin |
| Medicine Name LG-octaplas solution for infusion | Active Ingredients Human Plasma Proteins |
| Medicine Name Nuwiq powder and solvent for solution for injection | Active Ingredients simoctocog alfa |
| Medicine Name Octaplex 1000 IU coagulation factor IX per vial, powder and solvent for solution for infusion | Active Ingredients Human Prothrombin Complex |
| Medicine Name Octaplex 500 IU coagulation factor IX per vial, powder and solvent for solution for infusion | Active Ingredients Human Prothrombin Complex |
| Medicine Name Panzyga 100 mg/ml solution for infusion | Active Ingredients Human Normal Immunoglobulin |
| Medicine Name Wilate powder and solvent for solution for injection | Active Ingredients Factor VIII, von Willebrand factor |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 5 September 2019 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 5 September 2019 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
CC-REG029
Updated on 21 June 2019 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 May 2018 SPC
Reasons for updating
- Addition of joint SPC covering all presentations
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 May 2018 PIL
Reasons for updating
- Addition of joint PIL covering all presentations
Updated on 9 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 19 October 2017 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change from individual to joint SPC
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 19 October 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 7 June 2017 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may not be renewed (A)